Chordate Medical Holding
27 SEK +10.29%1 investor is following this company
Chordate Medical Holding is a medical technology company that has developed, patented and CE-marked a nerve-modulating treatment technique for chronic migraine and chronic nasal congestion (rhinitis), Kinetic Oscillation Stimulation (KOS). The company sells its products to treating clinics in selected European markets, Israel and Saudi Arabia, with the aim of increasing its presence in the global market.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CMH
Daily low / high price
23.44 / 27
SEK
Market cap
26.47M SEK
Turnover
102.4K SEK
Volume
4.3K
Financial calendar
Interim report
2024-11-22
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Lars Ingvarsson inkl bolag | 12.2 % | 12.2 % |
Hawoc Investment AB | 9.2 % | 9.2 % |
Isak Brandberg AB med närstående | 8.2 % | 8.2 % |
Tommy Hedberg | 7.6 % | 7.6 % |
Tor-Björn Bengtsson | 4.5 % | 4.5 % |
Nordnet Pensionsförsäkring AB | 2.7 % | 2.7 % |
Carsten Johansen | 2.5 % | 2.5 % |
David Nyman | 2.0 % | 2.0 % |
Simon Angeldorff | 1.9 % | 1.9 % |
Conny Holmström | 1.4 % | 1.4 % |
ShowingAll content types
Chordate Medical: BioStock: Lovande resultat i Chordates uppföljningsstudie
Chordate Medical: BioStock: Promising results in Chordate's follow-up study
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools